The effect of resveratrol on stroke

Investigating the effect of resveratrol on therapeutic outcomes of acute ischemic stroke patient receiving r-tPA

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191020045162N1

Enrollment

Registered

2020-03-12

Start date

2019-11-11

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Other cerebrovascular diseases

Interventions

Intervention 1: Intervention group: Patients with stroke receiving r-tPA who receive oral resveratrol capsule (150 mg every eight hours) and herbal medicine purchased from overseas and Packaged by pha

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ?All of acute ischemic stroke patient reciving r-tPA.

Exclusion criteria

Exclusion criteria: Pregnant patient Patients who received r-tPA more than 24 hours ago Previous cerebral hemorrhage and previous stroke

Design outcomes

Primary

Measure	Time frame
NIHSS : National Institutes of Health Stroke Scale. Timepoint: Symptoms onset - 24 hours later - discharge time. Method of measurement: Using a checklist and a special form that will be filled in according to the patient's history and examination.;Modified Rankin Scale (MRS). Timepoint: Before symptoms begin - three months later. Method of measurement: Based on specific forms that the patient or his / her companions will be asked to telephone or in person.;Barthel Index. Timepoint: Three months later. Method of measurement: Based on specific forms that the patient or his / her companions will be asked by phone or in person.	—

Measure

Time frame

NIHSS : National Institutes of Health Stroke Scale. Timepoint: Symptoms onset - 24 hours later - discharge time. Method of measurement: Using a checklist and a special form that will be filled in according to the patient's history and examination.;Modified Rankin Scale (MRS). Timepoint: Before symptoms begin - three months later. Method of measurement: Based on specific forms that the patient or his / her companions will be asked to telephone or in person.;Barthel Index. Timepoint: Three months later. Method of measurement: Based on specific forms that the patient or his / her companions will be asked by phone or in person.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPayam Sariaslani

Kermanshah University of Medical Sciences

drdparsa68@gmail.com+98 83 3427 6303

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026